Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA delivery to the brain in APOE ε4 carriers (PreventE4)
NCT03613844Phase 2Completed
- Sponsor
- University of Southern California
- Start
- Sep 2018
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docosahexaenoic acid in Alzheimer's disease (AD), sponsored by University of Southern California. Started Sep 2018; status: completed.
02
Drugs
docosahexaenoic acid
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03613844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03613844.